United States: FDA Third-Party Inspections
This voluntary program enables companies to combine FDA inspections with foreign certification audits, giving them more scheduling flexibility, limiting the administrative impact and streamlining the inspection process. LNE/G-MED is fully accredited under this program to conduct inspections of eligible class II and III medical device manufacturers, in conjunction with a wide range of other certification services, including ISO quality standards, CE Marking and other foreign requirements to allow for efficient market access to Canada, Europe, Asia and other world markets. Manufacturer EligibilityThe AP program is intended for manufacturers that operate in a global market and are likely to be subject to multiple inspection requirements. Therefore, manufactures must select an AP with the accreditation of the appropriate foreign country and request FDA clearance to use that specific AP. In addition, the manufacturer’s most recent inspection must have been classified by FDA as No Action Indicated (NAI) or Voluntary Action Indicated (VAI). Complete FDA Eligibility Rules Only 15 organizations are approved as an Accredited Person (AP) and LNE/G-MED is among the most active program participants. Our recognition by the FDA for quality system inspection and review of 510(k) submissions began over a decade ago through the U.S./European Mutual Recognition Agreement (MRA). LNE/G-MED is also among the first organizations able to perform join audits/inspections under the Pilot Multipurpose Audit Program (PMAP) developed by the FDA and Health Canada. AdvantagesRegulators put a high level of confidence in LNE/G-MED services, which is why you can trust us to provide a smooth audit/inspection process that stands up to scrutiny. As your partner, LNE/G-MED America is committed to helping you understand the regulations and considerations for combining certifications to access world markets and giving you:
LNE/G-MED America offers in-person, online and other customized training on a wide range of certification and quality topics. For details, check out our training schedule or request a customized program. Find Out MoreLNE/G-MED America offers in-person, online and other customized training on a wide range of certification and quality topics. For details, check out our training schedule or request a customized program.
|





- Progress Report - News
- MD Revisions Draft Amendments
- MD Classifications
- ISO 14971:2012
- MDD Revision: Actors, Roles and Responsabilities
- WEEE2 Directive
- Maintaining Compliance
- Revisions to the MDD
- ISO 13485 and FDA
- Controlling Outsourced Processes
- The Notified Body’s Role in Medical Device Certification
- EC Publishes E-Labeling Regulation
- IVD Updates
- Post-Market Phase
- IEC 60601 3rd Edition
- Tech File Evaluation
- Clinical Evaluation
- Recast of IVD Directive
- Own Brand Label Devices
- Software Engineering
- Med. Device Packaging
- Single Use Devices
- Usability Engineering
- FDA Use of ISO 13485
- Risk Management
- IVD Directive
- Switching Notified Body
- 60601 3rd Edition Status
- Regulatory News
- Ask Our Experts
- Free Guide: CE Marking
- Free Guide: IEC 60601 3rd Edition
- Free Guide: EMC Testing
- Free Guide: Brazil MD Approval
- Free Guide: Japan MD Approval
- Free Guide: IVD
- Technical FAQs
- Progress Report - News



Under the FDA's Inspection Program by Accredited Persons (AP), manufacturers that meet specific criteria can elect to have their choice of accredited third party inspect their facilities in lieu of an FDA official.


